<DOC>
	<DOCNO>NCT02817724</DOCNO>
	<brief_summary>The purpose study determine good integral strategy , m-health system , use addition supervise treatment , versus use m-health system alone , improve immediate long-term Quality Life breast cancer survivor .</brief_summary>
	<brief_title>Integral Strategy Supportive Care Breast Cancer Patients</brief_title>
	<detailed_description>Background : Technological support use e-health mobile application ( m-health ) promising strategy improve adherence healthy lifestyle breast cancer survivor ( excess energy intake low physical activity determinant risk recurrence , second cancer cancer mortality ) . Moreover , cancer rehabilitation program supervise health professional need due inherent characteristic breast cancer patient . Our main objective compare clinical efficacy m-health lifestyle intervention system alone versus integral strategy improve Quality Life ( QoL ) breast cancer survivor . Methods : This therapeutic superiority study use two-arm , assessor blind parallel randomized clinical trial ( RCT ) design . Women eligible : diagnosed stage I , II III-A breast cancer ; 25 75 year old ; Body Mass Index &gt; 25kg/m2 ; basic ability use mobile apps ; complete adjuvant therapy except hormone therapy ; functional shoulder limitation . Participants randomize one follow group : integral group use mobile application ( BENECA APP ) receive supervise rehabilitation ( 8-weeks ) ; m-health group use BENECA app 8-weeks . Study endpoint assess 8 week 24 week . The primary outcome QoL measure The European Organization Research Treatment Cancer Quality Life Questionnaire Core breast module . The secondary outcome : body composition ; upper-body functionality ( handgrip , Disability Arm , Shoulder Hand questionnaire , goniometry ) ; cognitive function ( Wechsler Adult Intelligence Scale , Trial Making Test ) ; anxiety depression ( Hospital Anxiety Depression Scale ) ; accelerometer . Discussion : This study design seek address new needs support treatment breast cancer survivor , reflect emerge need merge new low cost treatment option much-needed involvement health professional type patient .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Diagnosis stage I , II IIIA breast cancer . Overweight obese , accord Spanish Society Study Obesity . Basic ability use mobile apps live someone ability . Medical clearance participant . Completion adjuvant therapy except hormone therapy . Some functional Range Motion ( ROM ) limitation measure goniometry DASH Questionnaire . Have sign inform consent . History cancer recurrence . Chronic disease orthopedic issue would interfere ability participate rehabilitation program . Uncontrolled hypertension ( diastolic pressure &gt; 95mm Hg ) .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Breast Neoplasms</keyword>
	<keyword>survivor</keyword>
	<keyword>occupational therapy</keyword>
	<keyword>mobile application</keyword>
	<keyword>Quality Life</keyword>
</DOC>